Aurolife Pharma, LLC recalls Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carto…
- Recall date
- August 23, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-1868-2019
- FDA classification
- Class II
- Brand / firm
- Aurolife Pharma, LLC
- Sold / distributed
- Nationwide in the USA
Why it was recalled
Failed Impurities/Degradation Specifications
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.
Get recall alerts
Free email alert whenever Aurolife Pharma, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Aurolife Pharma, LLC